Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.88%
1,100.61
-9.73
-0.88%
—1,110.341,110.371,117.241,097.84——
SIXC
Communications
SIXC
Communications
SIXC
-1.33%
612.30
-8.24
-1.33%
—620.54620.54622.67611.42——
SIXE
Energy
SIXE
Energy
SIXE
+1.40%
1,175.46
+16.26
+1.40%
—1,159.201,160.591,177.621,156.21——
SIXI
Industrials
SIXI
Industrials
SIXI
-1.39%
1,729.12
-24.32
-1.39%
—1,753.441,749.081,762.011,724.74——
SIXM
Financials
SIXM
Financials
SIXM
-0.63%
644.73
-4.07
-0.63%
—648.80649.58655.73643.68——
SIXR
Staples
SIXR
Staples
SIXR
-0.65%
827.09
-5.40
-0.65%
—832.49832.07833.09826.15——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-1.98%
214.82
-4.34
-1.98%
—219.16219.16219.19214.82——
SIXT
Technology
SIXT
Technology
SIXT
+0.06%
3,115.17
+1.81
+0.06%
—3,113.363,120.793,143.643,105.16——
SIXU
Utilities
SIXU
Utilities
SIXU
-1.75%
910.43
-16.24
-1.75%
—926.67927.99930.54910.08——
SIXV
Health care
SIXV
Health care
SIXV
-1.01%
1,474.50
-15.11
-1.01%
—1,489.611,499.051,499.051,474.35——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,405.87
-17.39
-0.72%
—2,423.262,438.162,443.462,399.83——
EDIT:NASDAQ
Editas Medicine Inc
$3.30
-7.56%
(-0.27) 1D
$3.38
+2.42% (+0.080)
After hours
Closed: Apr 21, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EDIT...
Open
$3.59
High
$3.59
Low
$3.25
Mkt. cap
322.98M
Avg. vol.
1.77M
Volume
122.00
52-wk high
$4.54
52-wk low
$1.23
EPS
-$1.80
Beta
2.04
Shares outstanding
97.87M
No. of employees
87
News stories
From sources across the web
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc
CEO-
Employees87
FoundedNov 2013
Headquarters-
SectorBiotechnology
Websiteeditasmedicine.com
Last report
Mar 9, 2026
Fiscal Period
Q4 2025
Normalized EPS / Estimate
-0.06/ (-0.21 est.)USD
+72.08%beat
Revenue / Estimate
24.74M/ (8.77M est.)USD
+182.18%beat
Fiscal Q4 2025 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
4.66M
3.58M
7.54M
24.74M
Cost of goods sold
26.59M
16.18M
19.78M
27.40M
Cost of revenue
26.59M
16.18M
19.78M
27.40M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
13.38M
12.86M
12.32M
11.35M
Operating expense
13.38M
12.86M
12.32M
11.35M
Total operating expenses
39.97M
29.04M
32.09M
38.76M
Operating income
-35.31M
-25.46M
-24.55M
-14.02M
Other non operating income
-425.00K
-1.76M
-1.00K
2.18M
EBT including unusual items
-76.09M
-53.24M
-25.12M
-5.62M
EBT excluding unusual items
-35.24M
-27.15M
-25.12M
-9.69M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-76.09M
-53.24M
-25.12M
-5.62M
Net profit margin
-1,633.49%
-1,487.84%
-332.98%
-22.72%
Earnings per share
-0.92
-0.32
-0.28
-0.06
Interest and investment income
2.72M
2.09M
1.83M
2.14M
Interest expense
-2.22M
-2.02M
-2.40M
-
Net interest expenses
500.00K
67.00K
-568.00K
2.14M
Depreciation and amortization charges
-
-
-
-
EBITDA
-33.39M
-23.63M
-23.83M
-13.21M
Gain or loss from assets sale
3.72M
2.19M
-
34.00K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer